Geneva Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-392,416	Closed	-$17.8M	–	122
2020 Q1	$17.8M	Buy	+392,416	New	+$17.8M	0.51%	78